Grant: Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
University of British Columbia
$20,000.00
PRECISION: Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions
EF 2012-13
Résumé
People with inflammatory diseases of the skin, joint or bowel are no longer dying because of the first wave of inflammation. But, they are suffering and dying prematurely from chronic low grade inflammation. And, they often don't die from the disease directly but from its complications which are similar across the skin, joint and bowel diseases. The diseases we will study today affect 5.4 million Canadians and we will actually study about 1.3 million of them. The diseases include psoriasis and atopic dermatitis (skin diseases); rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus and lupus like diseases, gout and osteoarthritis (all joint diseases); and, Crohn's disease and ulcerative colitis (bowel diseases).
The complications we have identified as occurring in a greater frequency than would be expected by chance include: heart attacks, strokes, blood clots, infections, cancer, diabetes, lung disease, and hip fractures.
We will do the following:
1. Determine how common these complications are and determine their true impact on the people with the skin, joint and bowel diseases, including the costs.
2. Determine what factors predict a person with one of the skin, joint or bowel diseases will develop a complication. Some are known, some are suspected and some will be discovered as we will be learning from almost 1.3 million Canadians with the diseases that will be in the study.
3. Develop patient-centred approaches to reduce the frequency and consequences of the complications, or better still, eliminate them. We believe that with prompt diagnosis and more knowledge, prevention is possible. 5.4 million Canadians could live better lives and money will be saved by not treating complications that don't occur.
We have assembled a team that have been working for a decade on identifying the complications and doing test runs that show this is doable. This research could have huge impact.
Programme
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
276941
Name
Esdaile John M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Projecttitle
PRECISION: Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Keyworddelim
Administrative Data; Biomarkers; Cohort Studies; Cost-Effectiveness; Cure; Health Services; Population Research; Under-Serviced Populations
Abstract
People with inflammatory diseases of the skin, joint or bowel are no longer dying because of the first wave of inflammation. But, they are suffering and dying prematurely from chronic low grade inflammation. And, they often don't die from the disease directly but from its complications which are similar across the skin, joint and bowel diseases. The diseases we will study today affect 5.4 million Canadians and we will actually study about 1.3 million of them. The diseases include psoriasis and atopic dermatitis (skin diseases); rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus and lupus like diseases, gout and osteoarthritis (all joint diseases); and, Crohn's disease and ulcerative colitis (bowel diseases).
The complications we have identified as occurring in a greater frequency than would be expected by chance include: heart attacks, strokes, blood clots, infections, cancer, diabetes, lung disease, and hip fractures.
We will do the following:
1. Determine how common these complications are and determine their true impact on the people with the skin, joint and bowel diseases, including the costs.
2. Determine what factors predict a person with one of the skin, joint or bowel diseases will develop a complication. Some are known, some are suspected and some will be discovered as we will be learning from almost 1.3 million Canadians with the diseases that will be in the study.
3. Develop patient-centred approaches to reduce the frequency and consequences of the complications, or better still, eliminate them. We believe that with prompt diagnosis and more knowledge, prevention is possible. 5.4 million Canadians could live better lives and money will be saved by not treating complications that don't occur.
We have assembled a team that have been working for a decade on identifying the complications and doing test runs that show this is doable. This research could have huge impact.
Competitiondate
201211
Approvedterm2
1 yr 0 mth
Pinamesdelim
Esdaile, John M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $20,000~ $0~